Contents

Case Study 1

The SecAnim facility safely disposes of Category 1 MBM produced from onsite rendering and external sources utillising fluidised bed combustion technology. The fluidised bed provides complete destruction of pathogens and protein.

Case Study 2

Products derived from higher risk Category 1 and 2 ABP have limited applications and their use is forbidden in feed for farmed animals kept for the production of meat, milk and eggs.

Case Study 3

EFPRA wanted to ensure that their products remain competitive and that they play an active role in the sustainability discussions of the animal-based food supply chain.

Case Study 4

EFPRA commissioned two nutritional studies at Wageningen University to investigate the benefits of using PAPs in poultry and pig diets and to obtain up to date nutrient content and digestibility values for these products.

Case Study 5

By carefully segregating by-products from cattle, pig and fish, high value components are converted into specialised niche pharmaceutical products for medical treatments and dietary supplements for humans.

Case Study 6

QExtend PF12 is a fibrated protein derived from pork or beef-based plasma edible co-products. This revolutionary new ingredient can increase the valorisation of existing meat products by replacing up to 25% of the meat.

Case Study 7

Wastewater from the processing of animalby-products (ABP) is produced when water is evaporated from the ABP during processing.

Case Study 8

Products from the GZM Extraktionswerk AG Category 1 ABP processing facility in Lyss, Switzerland are used as renewable fuels and the heat and power produced are supplied to the Wärme Lyss Nord district heating scheme and adjacent industrial

Case Study 9

On average around 70% of ABP is moisture and this is evaporated in the rendering process. Along with additional process and cleaning water around 1 tonne of water must be evaporated per tonne of ABP processed.